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Abstract Article Info 
Introduction: Nasopharyngeal carcinoma (NPC) is an aggressive carcinoma come from postnasal space. 
Histology type of nasopharyngeal cell carcinoma and the staging that affect with management therapy. 
Nasopharyngeal carcinoma can be controlled by implementing evidence-based strategies of cancer and 
management of patients.  
Case report: Reported a case in 47-year-old man, diagnosis squamous cell carcinoma of nasopharynx 
with intracranial involvement.  
Conclusion: Histology type of nasopharyngeal carcinoma and the staging determined the modality of 
therapy and nasopharyngeal carcinoma prognosis 
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1. CASE REPORT 
Nasopharyngeal Carcinoma (NPC) is a malignant tumor from 
nasopharyngeal epithelium. The etiology of this malignant tumor is 
multifactorial, ethnic and geographical factors influence the risk of this 
disease [1]. The main etiology of nasopharyngeal malignancy always 
associated with Epstein Barr virus, genetic and environmental factors [2-4]. 
Nasopharyngeal Carcinoma are the fourth most common malignant 
tumors after cervical, breast and skin cancer and are the most common 
tumors in the head and neck [5]. 
Based on epidemiological data, NPC can be found in all countries 
where the highest incidence is in southern China, especially in Guangdong 
province and found in Europe and North America [6]. 
Incidence in Guangdong province in men reaches 20-50 per 100,000 
population per year [1]. In Cantonese in Guangdong province and Guangxi 
region it reaches more than 50 per 100,000 population per year [7]. NPC 
incidence in America is 1-2 cases per 100,000 men and 0.4 cases per 
100,000 women [8]. The geographical pattern of tumor events shows the 
interaction of environmental factors and genetic factors [9]. 
Nasopharynx is a cuboidal structure that is limited by the nasal cavity 
in the anterior, the skull base in the superior, the cervical spine in the 
posterior and the upper surface of the palate in the inferior. Eustachian tubes 
open toward the nasopharynx, some cranial nerves are also located nearby 
[10]. These malignancies can arise from various places in the nasopharynx, 
but are more common in the fossa of rosenmueller, which is located to the 
medial crura of the eustachian tube [11]. 
The nasopharynx is an area rich in lymphatic glands and blood 
vessels. This anatomic factor influence diagnosis, staging and treatment 
NPC [12]. The nasopharynx structure anatomy of Chinese and Asian is 
generally narrow compared to Caucasian so that make aerosol deposits 
and direct irritation leads to recurrent infections such as chronic 
pharyngitis which causes nasopharyngeal mucosa over a period of time 
certain changes to carcinoma [13]. 
Etiology of NPC is multifactorial. There are three main etiological 
factors associated with NPC, genetic, environmental and Epstein Barr virus 
infection. Epstein Barr virus infection factors are very dominant for 
nasopharyngeal carcinoma. Environment and genetics were also reported to 
be related to the incidence of NPC [2, 14].  
Genetic related to geographical variations. Although the pathogenesis 
mechanism of nasopharyngeal carcinoma is still unclear, familial 
aggregation has been well documented by many epidemiology study. 
Environmental factors include food factors, especially consumption of 
salted fish [15, 16]. Nitrosamines in salted fish are carcinogens for the 
development of NPC. In addition to other food factors such as smoking, 
exposure to formaldehyde, wood dust and chemicals are also risk factors for 
NPC begin with chronic inflammation of the nasopharynx [17].  
 Epstein-Barr Virus (EBV) infections occur in almost all cases of 
nasopharyngeal carcinoma, so individuals will have some antibodies against 
EBV [18]. Viral DNA join tumor cells. The 10 years risk of developing 
nasopharyngeal carcinoma estimated to be 200 times higher in the group 
with positive antibodies [15]. 
Presence of dysplasia in early lesion, which is a response to some 
environmental carcinogens. The area of dysplasia which is the origin of 
carcinoma but may not stand alone to cause further development. At this 
stage latent EBV infection causes development become more severe [9]. 
Epstein Barr Virus can be latent or lytic phases in host cells. Both 
phases are involved in carcinogenesis. In the latent phase, EBV encodes the 
onco-protein latent membrane protein, the Latent Membrane Protein 1 
(LMP1). Latent onco-protein 1 membrane protein is present in almost all 
nasopharyngeal carcinoma tissues. LMP1 is a 386-amino-acid protein and 
its active C-terminal region (CTAR) mediate some oncogenic signals, which 
contribute to oncogenic effect [19]. 
Nasopharyngeal carcinoma arises in the lateral wall, especially 
from the rossenmuller fossa [20]. Based on its anatomic location, NPC 
presents with one or more of 4 main symptom groups; first, nasal 
symptoms such as epistaxis, nasal obstruction and rhinorea; second, ear 
symptoms such as fully ears, hearing loss and tinnitus associated with 
eustachian tube dysfunction caused by tumor expansion lateral-
posteriorly; third, cranial nerve paralysis, most commonly nerves 3,5,6 
and 12, which are associated with superior expansion of tumors to the 
skull base. Patients complain of headaches, diplopia, facial pain and 
facial numbness; fourth, namely the symptoms of neck, usually appear 
enlarged lymph nodes at the top of the neck [11].  
NPC patient could have one or more four groups symptoms. These 
groups of symptoms are related to primary tumors, infiltration to structures 
around the nasopharynx or metastasis to the neck lymph nodes. Clinical 
symptoms generally consist of a lump in the neck, saliva mixed with blood, 
nasal obstruction and rhinorea, headache, neurological symptoms and 
hearing symptoms such as tinnitus and hearing loss [21]. 
When patient come with NPC symptoms, clinician should  do, ENT 
physical examination, performed enlargement of lymph nodes, fluid in the 
middle ear and cranial nerve examination. Clinical examination together 
with endoscopic examination can provide valuable information about tumor 
extension on the mucosal surface in the nasopharynx [21]. 
Primary tumors can be evaluated either by Computed Tomography (CT) 
scan or by Magnetic Resonance Imaging (MRI). MRI examination is more 
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sensitive than CT scanning to detect primary tumor and direct spread of soft 
tissue. Blood vessels are also clearly visible even without contrast. Although 
the diagnosis can be made based on clinical symptoms, it is recommended 
to confirm with histopathological examination with a biopsy [9]. 
Another investigation for diagnosis NPC is the estimation of antibody 
levels against EBV [21]. Immunoglobulin (Ig) A titer against Viral Capsid 
Antigen (VCA) EBV is now used as a screening test for high risk 
populations or NPC famiy patients [22]. 
Strategic location of the NPC and tumor tendency to invade 
surrounding tissue, first line therapy for NPC is radiotherapy. Local and 
regional NPC can managed adequate by radiotherapy, whereas the role of 
chemotherapy usually carried out for spreading tumors such as lymphatic 
and hematogenous [16]. 
Epstein Barr Virus is important factor related to cancer. Knowledge 
about EBV can be used to identify genotypes and biomarkers to be applied 
in primary prevention, early detection, and predictions of t severity [19]. 
Male, 47 years old came to outpatient clinic on August 15, 2018 with 
the chief complain having a swollen neck since 4 months and double vision. 
Patients refer from oncologist with post incisional lymph node abscess with 
suspected nasopharyngeal cancer.  
Physical examination, the general condition moderate, compos mentis, 
blood pressure 130/80 mmHg, respiration rate 20, heart rate 84, temperature 
within normal limit. Left and right ear within normal limit. External nose no 
deformity. Right nasal cavity wide, inferior turbinate within normal limit, no 
septum deviated. Left nasal cavity wide, inferior turbinate within normal limit, 
no septum deviated. Examination of the throat within normal limits. On posterior 
nasal endoscopy there is a mass in the nasopharynx. Eye examination: Ptosis (+), 
eye movement OD lateral-oblique superior inferior (-).  
Right cervical lymph node region, 4x4x2 cm lymph node was obtained, 
the consistency of solid, no pain in palpation and there was an incisional 
scar matrix. Left cervical lymph node region, 2x2x1 cm lymph node was 
obtained, the consistency of solid, no pain in palpation. (Picture 1). 
 
Picture 1. Right and left limph node examination 
Right nasal endoscopy examination (Picture 2): wide nasal cavity, 
inferior, medial, turbinate within normal limit, medial meatus medial 
widely open, there was no nasal discharge, there was no septum deviated. 
Left nasal endoscopy examination: wide nasal cavity, inferior and medial 
turbinate within normal limit, medial meatus medial widely open, there 
was no nasal discharge, there was no septum deviated. Nasopharynx there 
was mass in left and right fossa rosenmueller granular, hyperemic, there 
was post nasal drip.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Picture 2. Nasoendoskopi from right nasal cavity 
Base on that data we made working diagnostic nasopharyngeal mass. 
We plan for underwent biopsy. Laboratory examination hemoglobin 14.2 
g/dl, leukocytes 9,400/mm3, hematocrit 42%, platelets 444,000/mm3, 
Bleeding Time 2 second, Clothing Time 7 second. Patient consult to 
Anesthesia Department, result: no contraindication. 
Pathology anatomy result Nasopharyngeal Squamous cell carcinoma. 
Patient plan to staging with CT Nasopharynx, thorax x-ray, Abdomen 
Ultrasonography and bone survey.  
CT Nasopharynx with contras result: appears right nasopharyngeal 
mass obliterated rosenmueller fossa, torus tubarius and right parapharyngeal 
space, infiltrating right masticator muscle, destructing right temporal bone, 
destructing right sella bone, infiltrating intracranial with hypodense on the 
right frontoparietal-temporal bone, contrast enhanced. 
Thorax Rontgen, Abdomen ultrasonography and bone survey within 
normal limit and no sign of metastatic. Patient Diagnostic with NPC 
T4N2M0 Stage IVA and get management chemotherapy and radiotherapy. 
 
Picture 3. Nasopharynx computed tomograpy with contras  
2. DISCUSSION 
Male, 47 years old was diagnostic with Nasopharynx Squamous Cell 
Carcinoma, Age distribution for cases that have developed to NPC varies 
between countries in the world [13]. In Indonesia the incidence of NPC at 1-30 
years is 21%, with a peak occurrence at the age of 30-50 years [5]. 
Based on Indonesian cancer histopathology registration data in 2003, NPC 
was first ranked of all primary malignant tumors in men and eighth in women 
[23]. The male NPC incidence around 2-3 times higher than  female [23]. 
Chief complain in this patient, swollen neck and double vision. 
Nasopharynx has many regional lymphatic vessels, metastases often found 
and cervical lymphadenopathy often the only clinical manifestation 
complained of by patients with NPC [24]. In Lee et all study cited from Wei 
in 4,768 NPC patients the most common symptom neck swelling (75,8%), 
nasal symptoms (73.4%), ear symptoms (62.4%), headaches (34.8%), 
diplopia (10.7%), facial numbness (7.6%), weight loss (6.9%) and trismus 
(3.0%) [11]. Complaints and clinical symptoms in children with adults are 
generally the same. 
Nasal endoscopy examination this patient found a visible mass in the 
left and right rosenmueller fossa area. Endoscopic procedures cannot 
determine the third dimension of tumor growth, which is deep extension and 
includes erosion at the base of the skull and intracranial spread. This 
information can only be obtained by radiology examination. This 
investigation is very important to document the transmission of 
nasopharyngeal tumors and the involvement of surrounding tissues [21].  
The patient was biopsy, with the impression of a nasopharyngeal 
squamous cell carcinoma. The type of cell carcinoma very important on the 
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management and prognosis of subsequent patients. The World Health 
Organization (WHO) in 1991 grouped NPC into 3 subtypes. Type 1) 
Squamous cell carcinoma with keratin, Type 2) Squamous cell carcinoma is 
not differentiated, and type 3) Squamous cell carcinoma is not differentiated 
[25-29]. In 2005 WHO made the most recent NPC classification into: 1) 
Keratinous squamous cell carcinoma, 2) Basaloid squamous cell carcinoma 
[30]. The tumor's histopathology type also determines a non-differentiated 
squamous cell carcinoma and 3) undifferentiated squamous cell carcinoma. 
where undifferentiated carcinomas have a higher level of local tumor control 
with radiotherapy [20, 30]. 
This patient is undergoing tumor staging, based on clinical symptoms 
and physical examination such as double vision, limited eyeball movement 
and ptosis, intracranial involvement. CT Nasopharynx result: intracranial 
intervention, Thorax Rontgen, Abdomen ultrasonography and bone survey 
within normal limit and no sign of metastatic. From this examination can be 
concluded, patient with T4 and no metastatic. 
There were several stadium systems in NPC. The American Joint 
Committee on Cancer (AJCC) and International Union Against Cancer 
(UICC) systems are preferred in Europe and America. The old stadium 
system continues to be developed and revised, this is based on various 
experiences and clinical review obtained from various cancer centers in the 
world. The developed staging system must be based on several prognostic 
factors, such as the involvement of the skull base, cranial nerves, expansion 
of the primary tumor into the paranasopharyngeal space and the size of the 
lymph nodes of the neck [11]. 
Base on American Joint Committee on Cancer (AJCC) 8th edition 2018 
citated from National Comprehensive Cancer Network (NCCN) guidelines 
2019 [31]. NPC stage system:  
T Stage (T) 
Tx Primary tumor cannot be assessed 
T0 No tumor identified, but EBV-positive cervical node(s) 
involvement 
Tis Carcinoma in situ 
T1 Tumor confined to the nasopharynx, or extenion to 
oropharynx and/or nasal cavity without parapharyngeal 
involvement 
T2 Tumor with extension to parapharyngeal space, and/or 
adjacent soft tissue involvement (medial pterygoid, lateral 
pterygoid, prevertebral muscles) 
T3 Tumor with infiltration of bony structures at skull base, 
cervical vertebra, pterygoid structures, and/or paranasal 
sinuses 
T4 Tumor with intracranial extension, involvement of cranial 
nerves, hypopharynx, orbit, parotid gland, and/or extensive 
soft tissue infiltration beyond the lateral surface of the 
lateral pterygoid muscle  
N Stage (N) 
Nx Regional nodes cannot be assessed 
N0 No regional lymph node metastasis 
N1 Unilateral metastasis in cervical lymph node(s) and/or 
unilateral or bilateral metastasis in retropharyngeal lymph 
node(s), 6 cm or smaller in greatest dimension, above the 
caudal border of cricoid cartilage 
N2 Bilateral metastasis in cervical lymph node(s), 6 cm or 
smaller in greatest dimension, above the caudal border of 
cricoid cartilage 
N3 Unilateral or bilateral metastasis in cervical lymph node(s), 
larger than 6 cm in greatest dimension, and/or extension 
below the caudal border of cricoid cartilage 
M Stage (M) 
M0 No distant metastasis 
M1 Distant metastasis 
  
 
 
  
 
Stage 0 Tis N0 M0 
Stage I  T1 N0 M0 
Stage II T1,T0 N1 M0 
 T2 N0 M0 
 T2 N1 M0 
Stage III T1,T0 N2 M0 
 T2 N2 M0 
 T3 N0 M0 
 T3 N1 M0 
 T3 N2 M0 
Stage IVA T4 N0 M0 
 T4 N1 M0 
 T4 N2 M0 
 Any T N3 M0 
Stage IVB Any T Any N       M1 
      
Patient with staging IVA get management chemotherapy and 
radiotherapy this corresponding NCCN guideline that patient with T4N2M0 
get concurrant systemic therapy/RT followed by adjuvant chemotherapy. 
Prognostic this patient for 5 years survival around 30-55% life 
expectancy it all depends on recurrence and the presence of distant 
metastases in stage 1 and 2 NPC is around 72-90% [2]. NPC sufferers often 
have poor prognosis, it’s because late detection of clinical symptoms, lack 
of use of biomarkers for early detection and the low response of therapy that 
has been available so far [32]. 
3. CONCLUSION 
The histological type of NPC, Staging, modality therapy management 
that will be given is important role in determining the prognosis of the 
disease. The life expectancy of patients with nasopharyngeal malignant 
tumors with intracranial or metastatic involvement lower than 
nasopharyngeal malignant tumors in the absence of distant metastases or 
intracranial involvement. 
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